- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT01728207 | Unknown † | Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT01728207 | IMMU-114-01 | March 2013 | March 2017 | August 2017 | November 19, 2012 | February 1, 2016 |
|